Revolutionising access to critical biological medicines
A New Approach
to Biosimilars
Delivering high quality, life changing biosimilars through
the UK’s unique innovation capability and lifesciences eco-system
Our Mission
To revolutionise access to critical biological medicines
Biological medicines are vital to the health and wellbeing of an ever-increasing patient population.
Despite biosimilars vital role in expanding affordable access, many patients continue to be dependent on the originator’s branded product as the single source of supply even post patent.
Biosimax will partner with the NHS to both reduce cost and secure supply of these critical medicines.
A New Pathway
Accelerated biosimilar products pioneered within the UK medicines and healthcare systems
UK Supply Chain
Robust supply of critical biological medicines from the United Kingdom
Reduced Costs
Significant cost savings, enabling wider access to quality medicines
Highly Sustainable
Quickly cash-accretive, low risk and reproducible commercial business
Collaborative working with strategic partners
We have established several key partnerships which are complimentary to our substantial experience and expertise.
Delivering Revenue Faster
By leveraging new MHRA regulations & responding to NHS demand
